Financial report 2018 and Annual General Meeting 2019
Full year revenue growth of 5.5% and an operating profit margin of 10.2%
Performance highlights for full year 2018
Revenue from clients outside the Novo Nordisk Group increased by 13% driven by the international life sciences, public and enterprise customer groups all increasing double-digit
Due to a decline in revenue from the Novo Nordisk Group of 5.2% total revenue increased by 5.5